Correlation Between Anebulo Pharmaceuticals and Indaptus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Indaptus Therapeutics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Indaptus Therapeutics.

Diversification Opportunities for Anebulo Pharmaceuticals and Indaptus Therapeutics

0.12

Correlation Coefficient

Anebulo Pharmaceuticals  Indaptus Therapeutics

Average diversification

The 3 months correlation between Anebulo and Indaptus is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Indaptus Therapeutics go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Indaptus Therapeutics

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.51 times more return on investment than Indaptus Therapeutics. However, Anebulo Pharmaceuticals is 1.51 times more volatile than Indaptus Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  164.00  in Anebulo Pharmaceuticals on December 30, 2024 and sell it today you would lose (28.00) from holding Anebulo Pharmaceuticals or give up 17.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Indaptus Therapeutics

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Indaptus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Anebulo Pharmaceuticals and Indaptus Therapeutics

The main advantage of trading using opposite Anebulo Pharmaceuticals and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.

The idea behind Anebulo Pharmaceuticals and Indaptus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.